| | | | | | 2023 上半年 | 2023 上半年 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 往来方与上 | 上市公司核 | 2023 年期初 | 度往来累计 | 度往来资金 | 2023 上半年 | 2023 上半年 | 往来形成原 | 往来性 | | 其他关联方资金往来 | 资金往来方名称 | 市公司的关 | 算的会计科 | 往来资金余 | 发生金额 | 的利息（如 | 度偿还累计 | 期末往来资 | 因 | 质 | | | | 联关系 | 目 | 额 | （不含利 | 有） | 发生金额 | 金余额 | | | | | | | | | 息） | | | | | | | 上市公司的子公司及 | 深圳市金发拉比妇婴童用品有限公 | | | | | | | | 代垫费用及 | 非经营 | | 其附属企业 | 司 | 子公司 | 其他应收款 | 727.85 | 363.97 | | 394.73 | 697.09 | 往来款 | 性往来 | | | | | | | | | ...

一、审议通过了《关于公司 2023 年半年度报告全文及摘要的议案》 公司《 2023 年半年度报告》请详见公司指定信息披露网站巨潮资讯网 （www.cninfo.com.cn）；《2023 年半年度报告摘要》（2023-036 号）请详见公司发布 于指定信息披露媒体《中国证券报》、《证券时报》、《上海证券报》和巨潮资讯网 （www.cninfo.com.cn）上的公告。 表决结果：同意 7 票，反对 0 票，弃权 0 票。 二、审议通过了《关于监事会提请召开 2023 年第一次临时股东大会的议案》 公司董事会同意监事会提请召开股东大会的提议，决定于 2023 年 9 月 11 日召开公 司2023年第一次临时股东大会，审议《关于补选第五届监事会非职工代表监事的议案》。 请详见公司发布于指定信息披露媒体《中国证券报》、《证券时报》、《上海证券 报》和巨潮资讯网（www.cninfo.com.cn）上的《关于召开 2023 年第一次临时股东大会 的通知》（2023-038 号）。 证券代码：002762 证券简称：金发拉比 公告编号：2023-034号 金发拉比妇婴童用品股份有限公司 第五届董事会第四次会议决议公 ...

一、关于公司对外担保及关联方资金往来情况的独立意见 金发拉比妇婴童用品股份有限公司第五届董事会第四次会议 金发拉比妇婴童用品股份有限公司独立董事 关于第五届董事会第四次会议相关事项的独立意见 根据《中华人民共和国公司法》等法律、法规和规范性文件以及《金发拉比 妇婴童用品股份有限公司章程》、《金发拉比妇婴童用品股份有限公司独立董事工 作制度》等有关规定，我们作为金发拉比妇婴童用品股份有限公司（以下简称"公 司"）第五届董事会独立董事，经认真审阅相关材料，就公司第五届董事会第四 次会议相关事项发表独立意见如下： 根据中国证券监督管理委员会《关于规范上市公司与关联方资金往来以及上 市公司对外担保若干问题的通知》（证监发[2003]56 号）、《关于规范上市公司对 外担保行为的通知》（证监发[2005]120 号）及《深圳证券交易所上市公司自律 监管指南第 1 号——业务办理：4.1 定期报告披露相关事宜》等有关规定，结合 公司相关规章制度，作为公司独立董事，我们对 2023 年上半年度公司控股股东 及其关联方占用公司资金情况和公司对外担保情况进行了认真了解和查验，并发 表独立意见如下： 上述报告期内，公司不存在控股 ...

证券代码：002762 证券简称：金发拉比 公告编号：2023-038号 金发拉比妇婴童用品股份有限公司 关于召开 2023 年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 金发拉比妇婴童用品股份有限公司（以下简称"公司"）于2023年8月23日 召开了第五届董事会第四次会议，会议决定于2023年9月11日在汕头市金平区鮀 浦鮀济南路107号公司会议室召开公司2023年第一次临时股东大会，本次股东大 会将采用股东现场记名投票与网络投票表决相结合的方式召开，现将本次股东大 会的有关事项通知如下： 一、召开会议基本情况 1．股东大会届次：2023年第一次临时股东大会 2．股东大会的召集人：公司第五届董事会。 2023年8月25日，公司第五届监事会第四次会议审议通过了《关于提请董事 会召集召开2023年第一次临时股东大会的议案》，提请董事会召集召开股东大 会审议《关于补选第五届监事会非职工代表监事的议案》。经公司监事会提议， 公司第五届董事会第四次会议审议通过了《关于监事会提请召开2023年第一次 临时股东大会的议案》，同意召开本次临时股 ...

编号：20230509 投资者关系活动类别 □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 参与单位名称及人员姓名 投资者 时间 2023 年 5 月 9 日 15:00-17:00 地点 全景网路演系统 上市公司接待人员姓名 董事长：林浩亮先生；副董事长：汤典勤先生；董事、 总经理：林国栋先生；独立董事：蔡飙先生、姚明安先 生、纪传盛先生；财务总监：林贵贤先生；副总经理、 董事会秘书：薛平安先生。 投资者关系活动主要内容介绍 1、公司在母婴行业深耕多年，请问公司在产品研发方 面有哪些优势？ 答：尊敬的投资者您好！公司拥有多年培育的自有研发 团队，长期与国内国外顶尖设计团队合作，与汕头大学 等相关科研机构共建洗护产品实验室、研发设计中心， 公司通过多年投入和实践积累，已拥有自己独特的母婴 人体工学数据库，为公司研发"自然、安全、舒适、方 便、适合体质"的产品及更多的功能性新产品奠定了坚 实的基础。感谢您的关注！ 金发拉比妇婴童用品股份有限公司 投资者关系活动记录表 证券代码：002762 证券简称：金发拉比 | 2、你减持后又增持流通股，割了个波韭菜？对得 ...

Financial Performance - The company's revenue for Q1 2023 was ¥51,095,758.87, a decrease of 17.49% compared to ¥61,927,548.14 in the same period last year[5] - Net profit attributable to shareholders was ¥5,423,361.79, down 12.12% from ¥6,171,026.97 year-on-year[5] - The net profit for Q1 2023 was CNY 5,402,138.35, a decrease of 12.03% compared to CNY 6,137,952.63 in Q1 2022[20] - Operating profit for Q1 2023 was CNY 5,953,244.54, down 19.88% from CNY 7,427,411.91 in the same period last year[20] - The total comprehensive income for Q1 2023 was CNY 5,402,138.35, down from CNY 6,137,952.63 in Q1 2022, indicating a decline of 12.03%[21] Cash Flow and Investments - The net cash flow from operating activities increased by 55.75% to ¥5,252,145.61, compared to ¥3,372,186.91 in Q1 2022[5] - The cash flow from operating activities for Q1 2023 was CNY 5,252,145.61, an increase of 55.67% from CNY 3,372,186.91 in Q1 2022[23] - Investment activities generated a net cash flow of CNY 81,426,866.39 in Q1 2023, compared to a negative cash flow of CNY 69,493,119.15 in Q1 2022[23] - The company experienced a 100% increase in cash paid for investments, totaling ¥170,000,000.00, reflecting increased purchases of financial products[9] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥938,787,493.82, a slight decrease of 0.51% from ¥943,629,300.31 at the end of 2022[5] - Total assets as of March 31, 2023, were CNY 938,787,493.82, down from CNY 943,629,300.31 at the beginning of the year[17] - Total liabilities decreased to CNY 58,072,898.32 from CNY 66,621,191.16, a decline of 12.8%[17] - Total equity attributable to shareholders increased to CNY 880,746,920.88 from CNY 875,323,559.09, a rise of 0.5%[17] Shareholder Information - The number of common shareholders at the end of the reporting period was 60,110[11] - The top two shareholders, Lin Haoliang and Lin Ruowen, hold 28.29% and 25.95% of shares respectively, indicating significant ownership concentration[11] Earnings and Ratios - The basic earnings per share remained stable at ¥0.02, while diluted earnings per share decreased by 50% to ¥0.01[5] - The basic earnings per share for Q1 2023 remained stable at CNY 0.02, while diluted earnings per share decreased to CNY 0.01 from CNY 0.02 in Q1 2022[21] - The weighted average return on equity was 0.62%, slightly down from 0.63% in the previous year[5] Other Income and Expenses - The company reported a significant increase in cash and cash equivalents, rising by 56.73% to ¥240,373,426.18 due to the recovery of receivables[8] - Cash and cash equivalents increased to CNY 240,373,426.18 from CNY 153,372,003.80 at the beginning of the year, representing a growth of 56.7%[15] - The company reported a decrease in research and development expenses to CNY 2,469,173.74 from CNY 2,844,078.94, reflecting a reduction of 13.2% year-over-year[20] - The company experienced a significant increase in other income, which rose to CNY 278,341.03 from CNY 17,043.77 in the previous year[20] - The company received government subsidies amounting to ¥272,625.00, contributing to its financial performance[6] Inventory and Receivables - Accounts receivable decreased to CNY 11,097,709.61 from CNY 13,094,746.45, a decline of 15.2%[15] - Inventory decreased to CNY 107,830,751.05 from CNY 116,508,022.55, a reduction of 7.5%[16] - The company reported a 164.16% increase in cash received from other operating activities, totaling ¥606,851.73, primarily due to increased interest income[8]

Financial Performance - The company's operating revenue for 2022 was ¥245,364,844.20, a decrease of 18.03% compared to ¥299,319,917.27 in 2021[18]. - The net profit attributable to shareholders was -¥88,239,255.64, representing a decline of 729.99% from a profit of ¥14,006,552.11 in the previous year[18]. - The net profit after deducting non-recurring gains and losses was -¥90,707,219.36, down 845.52% from ¥12,167,029.37 in 2021[18]. - The basic earnings per share for 2022 was -¥0.25, a decrease of 725.00% from ¥0.04 in 2021[18]. - Total assets at the end of 2022 were ¥943,629,300.31, down 11.79% from ¥1,069,705,217.53 at the end of 2021[18]. - The net assets attributable to shareholders decreased by 10.80% to ¥875,323,559.09 from ¥981,298,263.06 in the previous year[18]. - Cash flow from operating activities was ¥29,556,879.38, a decline of 22.82% compared to ¥38,293,599.56 in 2021[18]. - The company reported a significant uncertainty regarding its ability to continue as a going concern due to negative net profits in recent years[18]. Market Trends and Industry Insights - The maternal and infant market in China is projected to exceed ¥4.6 trillion in 2022, with a year-on-year growth of 9%[33]. - The maternal and infant consumer goods market is expected to reach ¥5.4 trillion by 2024, indicating strong future growth potential[33]. - The offline maternal and infant retail sector is undergoing a "shuffle" with a store closure rate of 15%-20% in the first half of 2022[35]. - The domestic maternal and infant market is experiencing a shift towards online channels, with brands increasingly utilizing emerging platforms like Douyin for e-commerce[35]. - The maternal and infant product categories, particularly clothing, food, and supplies, are driving online sales growth, reflecting a competitive landscape among domestic and international brands[35]. - The Chinese medical beauty market is projected to reach approximately 230 billion yuan in 2022, maintaining double-digit growth despite a slowdown[37]. - The user base for medical beauty consumption in China is expected to exceed 20 million in 2022, with a forecast of 23.54 million by 2023[37]. Product Development and Innovation - The company has obtained 22 patents, including 15 invention patents, reflecting its commitment to innovation and quality[29]. - The company is developing a new antibacterial shampoo and conditioner product, aiming to expand its product line in the baby care market[142]. - The company is developing a new type of antibacterial concentrated laundry soap and micro-protein enzyme laundry capsules, aimed at improving the washing effect for baby clothes, with excellent antibacterial and mite removal functions[144]. - The new soluble deep hydration essence dry mask is designed to provide deep hydration and repair for wound damage, showcasing significant repair effects on skin injuries[143]. - The company is expanding its product categories to include new types of baby skincare products, focusing on zero-stimulation formulations suitable for delicate infant skin[143]. - The soluble dry mask technology aims to provide multiple functions, including deep hydration and wound repair, addressing the needs of consumers for advanced skincare solutions[143]. - The company is committed to ensuring product safety and effectiveness, particularly in the context of increasing parental awareness and demand for high-quality baby care products[144]. Sales and Marketing Strategies - The company is focusing on online channel expansion and the development of a new retail model that integrates online and offline operations[65]. - The company has established over 800 offline brand stores across various city tiers, supporting a comprehensive multi-channel marketing strategy[76]. - The company is enhancing its inventory management practices to reduce the risk of inventory depreciation and improve turnover rates[70]. - The company is actively collaborating with influencers and brands for cross-promotional activities to enhance brand visibility and attract consumers[98]. - The company is expanding its marketing efforts through a WeChat online and offline full-link marketing strategy to increase market share[148]. - The company is leveraging Australian Merino wool in its new cotton/wool blended products to enhance product competitiveness in the market[147]. Corporate Governance and Management - The company held a total of 4 shareholder meetings during the reporting period, reviewing 12 proposals[190]. - The board of directors consists of 7 members, including 3 independent directors, and held 11 meetings during the reporting period[191]. - The supervisory board convened 7 meetings to review and supervise periodic reports and related transactions, ensuring the protection of minority shareholders' interests[193]. - The company has established a complete and independent asset and business structure, ensuring no non-operating fund occupation by the controlling shareholder[195]. - The company maintains a clear and independent operational structure, with no competition with the controlling shareholder's other businesses[200]. - The company has implemented measures to ensure fair treatment of all shareholders, particularly minority shareholders, during decision-making processes[190]. Financial Management and Investment - The company's total cash inflow from investment activities dropped by 35.55% to ¥358,792,117.46, mainly due to a reduction in the recovery of financial products compared to the previous year[152]. - The net cash flow from financing activities showed a significant decrease of 54.84%, resulting in a net outflow of ¥21,786,912.89, compared to a larger outflow in the previous year[151]. - The company's total assets included ¥171,221,472.00 in long-term equity investments, which represented 18.14% of total assets, reflecting a decrease due to investment losses and impairment provisions[159]. - The company reported an investment loss of ¥13,526,349.85, accounting for 15.12% of total profit, primarily due to losses from long-term equity investments[157]. - The company has no significant securities or derivative investments during the reporting period, indicating a conservative investment strategy[164][165]. - The company did not engage in any fundraising activities during the reporting period, reflecting a focus on internal financing[166].

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 金发拉比妇婴童用品股份有限公司（以下简称"公司"）《2022 年年度报告及摘 要》经公司第五届董事会第二次会议审议通过，已于 2023 年 4 月 20 日在《中国证券 报》、《证券时报》、《上海证券报》和巨潮资讯网（www.cninfo.com.cn）等法定信 批媒体披露。 为便于广大投资者进一步了解公司《2022 年年度报告》和公司生产经营情况，公 司将于 2023 年 5 月 9 日（星期二）下午 15:00 至 17:00 在全景网提供的网上平台举 办 2022 年度网上业绩说明会。 本次网上业绩说明会将采用网络远程方式举行，投资者可登陆投资者互动平台 "全景·路演 （http://rs.p5w.net）"参与本次网上业绩说明会。 证券代码：002762 证券简称：金发拉比 公告编号：2023-021号 金发拉比妇婴童用品股份有限公司 关于举办 2022 年度网上业绩说明会的公告 现场出席本次网上业绩说明会的人员有：林浩亮（董事长）、汤典勤（副董事长）、 林国栋（总经理）、蔡飙（独立董事）、姚明安（独立 ...

Financial Performance - Revenue for Q3 2022 was CNY 56,432,860.91, a decrease of 28.50% compared to the same period last year[5] - Net profit attributable to shareholders was CNY -409,734.40, a decline of 95.93% year-on-year[5] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY -1,083,775.49, down 90.22% from the previous year[5] - Total operating revenue for the current period is ¥178,975,782.45, a decrease of 14.06% from ¥208,266,288.91 in the previous period[17] - Net profit for the current period is ¥10,236,190.39, an increase of 57.00% compared to ¥6,482,188.15 in the previous period[20] - Total tax expenses for the current period are ¥3,066,780.28, compared to a tax benefit of -¥2,067,270.52 in the previous period[20] - Basic and diluted earnings per share for the current period are both ¥0.03, up from ¥0.02 in the previous period[20] Assets and Liabilities - Total assets at the end of Q3 2022 were CNY 1,056,710,642.94, a decrease of 1.21% from the end of the previous year[5] - Total assets decreased from RMB 1,069,705,217.53 to RMB 1,056,710,642.94, a decline of about 1.2%[16] - Total liabilities decreased from RMB 86,467,703.90 to RMB 80,888,188.92, a reduction of approximately 6.1%[16] - The company's total equity decreased from RMB 983,237,513.63 to RMB 975,822,454.02, a decline of about 0.4%[16] Cash Flow - Cash flow from operating activities showed a net outflow of CNY -12,170,296.19, an increase of 24.48% in outflow compared to the previous year[5] - Operating cash flow net amount is -¥12,170,296.19, an improvement from -¥16,115,510.56 in the previous period[23] - Cash and cash equivalents at the end of the period are ¥75,539,671.69, down from ¥88,044,601.18 in the previous period[23] - Investment activities generated a net cash flow of -¥69,501,783.03, worsening from -¥19,024,841.35 in the previous period[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 43,059[11] - The largest shareholder, Lin Haoliang, holds 29.29% of the shares, totaling 103,708,550 shares[11] - The number of shareholders with voting rights restored for preferred shares is 0[11] Other Financial Metrics - The company reported a significant increase in prepayments, up 181.40% to CNY 19,130,658.30, mainly due to prepayments for projects and new product purchases[9] - Other current assets increased by 171.75% to CNY 95,827,444.33, attributed to the purchase of financial products[9] - Investment income for the first nine months was CNY 3,849,781.23, a significant increase of 471.05% compared to the same period last year[9] - The company recorded a 248.35% increase in income tax expenses, amounting to CNY 3,066,780.28, due to the recognition of deferred tax assets in the previous year[10] - Cash received from investment decreased by 47.63% to CNY 220,000,000.00, primarily due to a reduction in financial products compared to the previous year[10] - Accounts receivable increased from RMB 17,995,306.88 to RMB 23,298,715.73, representing a growth of about 29.5%[14] - Inventory rose from RMB 150,617,302.09 to RMB 159,415,555.37, an increase of approximately 5.3%[15] Research and Development - Research and development expenses for the current period are ¥10,315,414.82, a decrease of 6.52% from ¥11,032,931.74 in the previous period[17] Company Developments - The company has not disclosed any new product or technology developments in the current report[12] - The third quarter report of Jinfalabi Baby Products Co., Ltd. is unaudited[24]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥122,542,921.54, a decrease of 5.25% compared to ¥129,338,748.73 in the same period last year[22]. - The net profit attributable to shareholders was ¥10,718,527.31, down 35.72% from ¥16,675,852.88 in the previous year[22]. - Basic and diluted earnings per share decreased by 40.00%, from ¥0.05 to ¥0.03[22]. - Total assets at the end of the reporting period were ¥1,059,340,102.78, a decrease of 0.97% from ¥1,069,705,217.53 at the end of the previous year[22]. - The net assets attributable to shareholders decreased by 0.71%, from ¥981,298,263.06 to ¥974,315,540.37[22]. - The weighted average return on net assets was 1.09%, down from 1.68% in the previous year[22]. - The company's total revenue for the reporting period was ¥122,542,921.54, a decrease of 5.25% compared to ¥129,338,748.73 in the previous year[68]. - Revenue from the maternal and infant consumer goods sector was ¥115,031,168.02, accounting for 93.87% of total revenue, down 9.18% from ¥126,652,002.29[69]. - The total profit for the first half of 2022 was CNY 13,005,958.75, a decline of 28.0% from CNY 18,061,598.94 in the first half of 2021[182]. - The company's operating profit was CNY 13,325,250.80, down 26.1% from CNY 17,980,661.96 in the same period last year[181]. Cash Flow and Investments - The net cash flow from operating activities improved by 27.08%, reaching -¥11,995,267.80 compared to -¥16,451,015.02 in the same period last year[22]. - The company reported a net cash flow from investment activities of -69,737,171.24 for the first half of 2022, compared to -2,834,697.24 in the same period of 2021, showing a substantial increase in cash outflow[189]. - Cash flow from financing activities resulted in a net outflow of -16,760,593.55 in the first half of 2022, an improvement from -40,859,321.82 in the same period of 2021[189]. - The total cash and cash equivalents at the end of the first half of 2022 were 76,057,466.78, down from 103,908,741.68 at the end of the first half of 2021, representing a decrease of approximately 26.8%[188]. - The company reported investment income of CNY 2,603,964.39, an increase from CNY 2,098,360.21 in the previous year[181]. Market Strategy and Product Development - The company focuses on mid-to-high-end maternal and infant consumer products, operating three main brands: "LABI BABY," "XIAYIDAI," and "BABY LABI"[30]. - The company is advancing its strategy of "products + services + internet," aiming to integrate maternal and infant products with medical and aesthetic services[31]. - The company aims to enhance its "product + service" comprehensive solution capabilities in the maternal and infant market[65]. - The company is focused on integrating its maternal and infant product business with medical and aesthetic services to create a new business model[60]. - The company plans to expand its market presence through new product launches and strategic partnerships in the upcoming quarters[198]. Operational Efficiency and Supply Chain - The company has been actively optimizing its supply chain to provide higher quality products and services, ensuring strict selection of raw materials and quality control[58]. - The company has adopted a mixed production model, combining self-owned factories, commissioned processing, and outsourced production to ensure quality control[49]. - The company is addressing raw material price fluctuations by optimizing procurement and production processes to control costs[111]. - The company aims to enhance its supply chain efficiency to support future growth initiatives[198]. Research and Development - Research and development expenses decreased by 11.01% to ¥6,598,846.55 from ¥7,415,453.83[68]. - The company has accumulated 10 invention patents, 9 utility model patents, and 25 design patents, reflecting its commitment to innovation[62]. - Research and development expenses increased by 10% year-over-year, highlighting the company's commitment to innovation[198]. Sales and Marketing - The company has increased online sales efforts by building an "Internet Live Streaming Base," expanding live streaming sessions, and optimizing e-commerce teams, with a focus on platforms like Douyin and WeChat[53]. - The company has optimized its offline channel strategy, adjusting store layouts based on market changes, and enhancing the experiential and service functions of physical stores[55]. - The company operates a multi-channel sales system, including offline brand specialty stores, a dealer network, and online platforms such as mainstream e-commerce sites and WeChat mini-programs[77]. Corporate Governance and Compliance - The company has maintained its board and management structure without any changes during the reporting period[117]. - The company has not experienced any major litigation or arbitration matters during the reporting period[131]. - There were no significant environmental violations or penalties reported during the period, and the company complies with local environmental regulations[123]. Shareholder Information - The total number of shareholders at the end of the reporting period was 48,179[158]. - The largest shareholder, Lin Ruowen, had a reduction of 4,904,683 restricted shares, leaving her with 71,210,473 shares[156]. - The total number of restricted shares decreased from 158,230,687 to 152,906,604, a reduction of 5,324,083 shares, representing a decrease of approximately 3.36%[154]. Social Responsibility - The company made a charitable donation of RMB 300,000 to support local communities in need, reflecting its commitment to social responsibility[124].